11 Blockbuster 'Drugs To Watch' In 2015

Eleven blockbuster drugs will debut on the pharmaceutical market this year, and each is expected to pull in at least $1 billion in revenue within five years of launch, according to Thomson Reuters' annual "Drugs to Watch" report. The drugs represent some of the most lucrative opportunities during the coming years for 10 companies with candidates on the list, including Novartis, Pfizer and Sanofi.